Science 37 Holdings Valuation
| SNCEDelisted Stock | USD 0.28 0.02 7.69% |
Science 37 seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Science 37 Holdings from inspecting the company fundamentals such as Shares Outstanding of 6.03 M, return on equity of -1.19, and Operating Margin of (0.60) % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Science 37's price fluctuation is very steady at this time. Calculation of the real value of Science 37 Holdings is based on 3 months time horizon. Increasing Science 37's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Science stock is determined by what a typical buyer is willing to pay for full or partial control of Science 37 Holdings. Since Science 37 is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Science Stock. However, Science 37's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.28 | Real 0.23 | Hype 0.28 | Naive 0.31 |
The real value of Science Stock, also known as its intrinsic value, is the underlying worth of Science 37 Holdings Company, which is reflected in its stock price. It is based on Science 37's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Science 37's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Science 37 Holdings helps investors to forecast how Science stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Science 37 more accurately as focusing exclusively on Science 37's fundamentals will not take into account other important factors: Science 37 Total Value Analysis
Science 37 Holdings is at this time forecasted to have valuation of (21.22 M) with market capitalization of 34.66 M, debt of 1.32 M, and cash on hands of 130.24 M. The negative valuation of Science 37 may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Science 37 fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(21.22 M) | 34.66 M | 1.32 M | 130.24 M |
Science 37 Investor Information
About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.67. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Science 37 Holdings recorded a loss per share of 21.4. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 8th of December 2023. Based on the key measurements obtained from Science 37's financial statements, Science 37 Holdings is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Science 37 Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Science 37 has an asset utilization ratio of 47.66 percent. This indicates that the Company is making $0.48 for each dollar of assets. An increasing asset utilization means that Science 37 Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Science 37 Ownership Allocation
The market capitalization of Science 37 is $34.66 Million. Over half of Science 37's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Science 37 Profitability Analysis
The company reported the previous year's revenue of 60.26 M. Net Loss for the year was (124.65 M) with profit before overhead, payroll, taxes, and interest of 20.07 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Science 37's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Science 37 and how it compares across the competition.
About Science 37 Valuation
The delisted stock valuation mechanism determines Science 37's current worth on a weekly basis. Our valuation model uses a comparative analysis of Science 37. We calculate exposure to Science 37's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Science 37's related companies.Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. Science 37 operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 601 people.
Science 37 Growth Indicators
Investing in growth stocks can be very risky. If the company such as Science 37 does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 115.9 M | |
| Shares Float | 4 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges |